← Back to Search

Procedure

Adolescent Overweight for Type 1 Diabetes (T1D Trial)

N/A

Waitlist Available

Led By Michelle Van Name, MD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 240 minutes

Awards & highlights

T1D Trial Summary

This trial will look at how extra weight (adiposity) affects insulin's ability to control blood sugar in obese adolescents with type 1 diabetes. It will also examine how fatty liver disease affects insulin resistance in these teens.

Eligible Conditions

Type 1 Diabetes
Obesity

T1D Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 240 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~240 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 240 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Hepatic Sensitivity to Low Dose Insulin

Peripheral Sensitivity to High Dose Insulin

Rate of Glucose Metabolism

+1 more

T1D Trial Design

3Treatment groups

Experimental Treatment

Group I: Young AdultExperimental Treatment1 Intervention

Young adults with T1D with a euglycemic hyperinsulinemic clamp with tracer enhancement

Group II: Adolescent TypicalExperimental Treatment1 Intervention

Lean adolescents with T1D

Group III: Adolescent OverweightExperimental Treatment1 Intervention

Adolescents with T1D and overweight/obesity

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor

1,847 Previous Clinical Trials

2,737,645 Total Patients Enrolled

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,357 Previous Clinical Trials

4,315,163 Total Patients Enrolled

Michelle Van Name, MDPrincipal InvestigatorYale University

1 Previous Clinical Trials

15 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any fresh participants being enlisted in this research effort?

"Clinicaltrials.gov details that this medical trial is currently recruiting participants. It was posted on January 1st 2019, and recently updated on April 14th 2022."

Answered by AI

For which demographic might the research findings be most applicable?

"This research is recruiting 108 human subjects with varying levels of adiposity between the ages of 12 and 24. It's essential that they meet all these criteria: Tanner stage 2-5, BMI under 75th percentile for slim participants or above 85th for overweight/obese patients; age range from 12 - 16 years old as well as 18 - 24; both a parent signature providing consent and participant agreeing to assent are necessary."

Answered by AI

Are septuagenarians being enrolled for the experiment?

"This medical trial has an age restriction, admitting patients between the ages of 12 and 24 years old."

Answered by AI

What is the current patient count for this research project?

"Affirmative. According to information published on clinicaltrials.gov, this medical trial is actively searching for applicants - the posting was first made in January 2019 and was last edited nearly four years later on April 14th 2022. The research team is seeking 108 individuals across a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effect of Adiposity on Hepatic and Peripheral Insulin Resistance in Type 1 Diabetes

2019. "Effect of Adiposity on Hepatic and Peripheral Insulin Resistance in Type 1 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03582956.